Ophthalmology · Worcester, MA
NPI
1457327728
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
5 Neponset St
Worcester, MA, 01606
Phone (508) 856-9599
Groups this clinician bills Medicare through
Medicare paid, 2024
$245K
2,066 services
Medicare patients, 2024
878
Average age 76
Drug cost, 2024
$572K
5,622 prescriptions
Company payments, 2025
$1,712
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eugenio M Candal was code 92014 (ophthalmological e&m), 307 times for 294 patients. In total Eugenio M Candal billed 2,066 services in 27 codes, and Medicare paid $245K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-09-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 307 | 294 | $95.03 | $29K |
| 99214 Office E&M - Established | Office | 283 | 268 | $101.98 | $29K |
| 92012 Ophthalmological E&M | Office | 274 | 228 | $67.06 | $18K |
| 66984 Cataract Surgery | Facility | 237 | 151 | $434.00 | $103K |
| 92136 Ultrasound - Nonspecific | Office | 181 | 145 | $36.03 | $6,522 |
| 92133 Computerized Ophthalmic Imaging | Office | 165 | 153 | $25.97 | $4,285 |
| 92004 Ophthalmological E&M | Office | 159 | 159 | $120.74 | $19K |
| 92083 Vision, Hearing, and Speech Services | Office | 97 | 96 | $42.03 | $4,077 |
| 92134 Computerized Ophthalmic Imaging | Office | 94 | 92 | $33.45 | $3,144 |
| 68761 Eye | Office | 69 | 27 | $97.00 | $6,693 |
| 99213 Office E&M - Established | Office | 53 | 46 | $75.32 | $3,992 |
| 99204 Office E&M - New | Office | 18 | 18 | $136.90 | $2,464 |
| 92250 Angiography | Office | 17 | 17 | $32.87 | $559 |
| 92002 Ophthalmological E&M | Office | 15 | 15 | $69.73 | $1,046 |
| 92285 Standard X-ray | Office | 13 | 13 | $19.85 | $258 |
By year: 2022 $211K for 2,094 services; 2023 $230K for 2,215 services; 2024 $245K for 2,066 services.
Medicare prescription drug claims, 2024
In 2024, the drug Eugenio M Candal prescribed most often to Medicare patients was Latanoprost, with 1,620 prescriptions and refills. In total Eugenio M Candal wrote 5,622 Medicare prescriptions that cost $572K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,620 | 3,869 | 568 | $24K |
| Prednisolone Acetate Generic | 502 | 633 | 368 | $29K |
| Timolol Maleate Generic | 480 | 1,137 | 161 | $14K |
| Brimonidine Tartrate Generic | 350 | 708 | 116 | $13K |
| Flurbiprofen Sodium Generic | 306 | 354 | 212 | $30K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 272 | 651 | 113 | $6,032 |
| Ofloxacin Generic | 266 | 322 | 207 | $4,733 |
| Moxifloxacin Moxifloxacin Hcl | 225 | 227 | 127 | $5,202 |
| Erythromycin Erythromycin Base | 204 | 205 | 187 | $2,583 |
| Ketorolac Tromethamine Generic | 204 | 255 | 124 | $4,096 |
| Lumigan Bimatoprost | 139 | 262 | 45 | $71K |
| Dorzolamide Hcl Generic | 138 | 321 | 56 | $3,174 |
| Travoprost Generic | 87 | 191 | 30 | $20K |
| Cyclosporine Generic | 60 | 140 | 28 | $33K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 56 | 56 | 45 | $618 |
Brand drugs: 1,404 claims; generic drugs: 4,218 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eugenio M Candal $1,712 ($1,712 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbvie Inc. with $518.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 20 | $518 |
| Dompe US, Inc. | 6 | $358 |
| Glaukos Corporation GKOS | 2 | $239 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 8 | $175 |
| Oyster Point Pharma, Inc. | 4 | $123 |
| Tarsus Pharmaceuticals, Inc. TARS | 4 | $110 |
| Bausch & Lomb Americas Inc. BLCO | 4 | $82.04 |
| Alcon Vision LLC ALC | 4 | $80.11 |
| ANI Pharmaceuticals, Inc. ANIP | 1 | $26.72 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.